Jonathan Tobin - Profile and Investment Details

Investor Profile

Jonathan Tobin is a Venture Capital, Private Equity Firm, Angel/Individual, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Myricx Pharma Ltd, Atox Bio, Genomics England, Stealth Biotech, Artios Pharma Ltd, Arix Bioscience plc, KHAN Technology Transfer Fund IDepixus, AstronauTx, CatalYm GmbH, Quench Bio, NRG Therapeutics, Inivata, STipe Therapeutics, Auspherix, Cincera Therapeutics Pty Ltd, VelosBio, Cancer Research Horizons, Abingdon Health, Pheon Therapeutics, . Over time, Jonathan Tobin has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jonathan Tobin is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Immunotherapy, Healthcare Innovation, Life Science, Health Technology, Portfolio Management, Medical Technologies, Finance, Biotechnology, Medical Devices, Drug Development, Market Research, Entrepreneurship, Health and Hospital Services, Clinical Trials, Gene Therapy, UK-based Startups, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jonathan Tobin, as their portfolio suggests a familiarity and interest in this area.

Understanding Jonathan Tobin’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.